Patents by Inventor Ling-Ling Kang

Ling-Ling Kang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210205593
    Abstract: A device for sustained delivery of a poorly water soluble drug is described. A drug reservoir within the device, when in operation, contains an aqueous suspension of the drug mixed with a suspension of an excipient that, in one embodiment, generates acidic groups for a sustained period of time to maintain a desired pH in the aqueous suspension that in turn provides a constant concentration of a soluble form of the drug.
    Type: Application
    Filed: March 18, 2021
    Publication date: July 8, 2021
    Inventors: Francis J. Martin, Ling-Ling Kang
  • Patent number: 10974036
    Abstract: A device for sustained delivery of a poorly water soluble drug is described. A drug reservoir within the device, when in operation, contains an aqueous suspension of the drug mixed with a suspension of an excipient that, in one embodiment, generates acidic groups for a sustained period of time to maintain a desired pH in the aqueous suspension that in turn provides a constant concentration of a soluble form of the drug.
    Type: Grant
    Filed: July 10, 2019
    Date of Patent: April 13, 2021
    Assignee: Delpor, Inc.
    Inventors: Francis J. Martin, Ling-Ling Kang
  • Publication number: 20190329012
    Abstract: A device for sustained delivery of a poorly water soluble drug is described. A drug reservoir within the device, when in operation, contains an aqueous suspension of the drug mixed with a suspension of an excipient that, in one embodiment, generates acidic groups for a sustained period of time to maintain a desired pH in the aqueous suspension that in turn provides a constant concentration of a soluble form of the drug.
    Type: Application
    Filed: July 10, 2019
    Publication date: October 31, 2019
    Inventors: Francis J. Martin, Ling-Ling Kang
  • Patent number: 10391288
    Abstract: A device for sustained delivery of a poorly water soluble drug is described. A drug reservoir within the device, when in operation, contains an aqueous suspension of the drug mixed with a suspension of an excipient that, in one embodiment, generates acidic groups for a sustained period of time to maintain a desired pH in the aqueous suspension that in turn provides a constant concentration of a soluble form of the drug.
    Type: Grant
    Filed: December 22, 2016
    Date of Patent: August 27, 2019
    Assignee: Delpor, Inc.
    Inventors: Francis J. Martin, Ling-Ling Kang
  • Publication number: 20170100571
    Abstract: A device for sustained delivery of a poorly water soluble drug is described. A drug reservoir within the device, when in operation, contains an aqueous suspension of the drug mixed with a suspension of an excipient that, in one embodiment, generates acidic groups for a sustained period of time to maintain a desired pH in the aqueous suspension that in turn provides a constant concentration of a soluble form of the drug.
    Type: Application
    Filed: December 22, 2016
    Publication date: April 13, 2017
    Inventors: Francis J. Martin, Ling-Ling Kang
  • Patent number: 9561352
    Abstract: A device for sustained delivery of a poorly water soluble drug is described. A drug reservoir within the device, when in operation, contains an aqueous suspension of the drug mixed with a suspension of an excipient that, in one embodiment, generates acidic groups for a sustained period of time to maintain a desired pH in the aqueous suspension that in turn provides a constant concentration of a soluble form of the drug.
    Type: Grant
    Filed: March 11, 2010
    Date of Patent: February 7, 2017
    Assignee: Delpor, Inc.
    Inventors: Francis J. Martin, Ling-Ling Kang
  • Patent number: 8114430
    Abstract: Liquid polyoxaester polymer materials are provided as suspending vehicles suitable for dispensing of pharmaceutically active agents, such as proteins, from delivery devices, for example, pump-driven dosage forms. Polyoxaesters are made from at least one diacid and at least one diol. Through the use of polyoxaesters virtually solvent-free pharmaceutical suspensions can be created.
    Type: Grant
    Filed: May 3, 2011
    Date of Patent: February 14, 2012
    Assignee: Intarcia Therapeutics, Inc.
    Inventors: Catherine Manya Rohloff, Stephen Andrew Berry, Ling-Ling Kang, Aruna Nathan
  • Publication number: 20110264076
    Abstract: Liquid polyoxaester polymer materials are provided as suspending vehicles suitable for dispensing of pharmaceutically active agents, such as proteins, from delivery devices, for example, pump-driven dosage forms. Polyoxaesters are made from at least one diacid and at least one diol. Through the use of polyoxaesters virtually solvent-free pharmaceutical suspensions can be created.
    Type: Application
    Filed: May 3, 2011
    Publication date: October 27, 2011
    Inventors: Catherine Manya Rohloff, Stephen Andrew Berry, Ling-Ling Kang, Aruna Nathan
  • Patent number: 7959938
    Abstract: Liquid polyoxaester polymer materials are provided as suspending vehicles suitable for dispensing of pharmaceutically active agents, such as proteins, from delivery devices, for example, pump-driven dosage forms. Polyoxaesters are made from at least one diacid and at least one diol. Through the use of polyoxaesters virtually solvent-free pharmaceutical suspensions can be created.
    Type: Grant
    Filed: March 13, 2006
    Date of Patent: June 14, 2011
    Assignee: Intarcia Therapeutics, Inc.
    Inventors: Catherine Manya Rohloff, Stephen Andrew Berry, Ling-Ling Kang, Aruna Nathan
  • Publication number: 20110106006
    Abstract: A device for sustained delivery of a poorly water soluble drug is described. A drug reservoir within the device, when in operation, contains an aqueous suspension of the drug mixed with a suspension of an excipient that, in one embodiment, generates acidic groups for a sustained period of time to maintain a desired pH in the aqueous suspension that in turn provides a constant concentration of a soluble form of the drug.
    Type: Application
    Filed: March 11, 2010
    Publication date: May 5, 2011
    Inventors: Francis J. Martin, Ling-Ling Kang
  • Publication number: 20070178159
    Abstract: A composition includes a viscous gel formed from a combination of a biodegradable polymer and a biocompatible solvent. The composition also includes a hydrophilic porogen, which may be incorporated in the viscous gel. The composition may form a porous scaffold in situ.
    Type: Application
    Filed: January 17, 2007
    Publication date: August 2, 2007
    Applicant: ALZA CORPORATION
    Inventors: Guohua Chen, Zhongli Ding, Johanna Bentz, Paul Houston, Ling-Ling Kang
  • Publication number: 20060246138
    Abstract: Liquid polyoxaester polymer materials are provided as suspending vehicles suitable for dispensing of pharmaceutically active agents, such as proteins, from delivery devices, for example, pump-driven dosage forms. Polyoxaesters are made from at least one diacid and at least one diol. Through the use of polyoxaesters virtually solvent-free pharmaceutical suspensions can be created.
    Type: Application
    Filed: March 13, 2006
    Publication date: November 2, 2006
    Inventors: Catherine Rohloff, Stephen Berry, Ling-Ling Kang, Aruna Nathan